Csermely A[au] - Search Results

Year	Number of Results
1975	1
1981	2
1982	2
1983	1
1985	2
1986	3
1988	1
2008	1
2019	1
2020	3
2021	4
2022	11
2023	7
2024	1

1

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials.

Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Targher G. Mantovani A, et al. Among authors: csermely a. Metabolites. 2021 Jan 27;11(2):73. doi: 10.3390/metabo11020073. Metabolites. 2021. PMID: 33513761 Free PMC article. Review.

2

Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.

Mantovani A, Petracca G, Beatrice G, Csermely A, Tilg H, Byrne CD, Targher G. Mantovani A, et al. Among authors: csermely a. Gut. 2022 Apr;71(4):778-788. doi: 10.1136/gutjnl-2021-324191. Epub 2021 Mar 8. Gut. 2022. PMID: 33685968

3

Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.

Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, Byrne CD, Targher G. Mantovani A, et al. Among authors: csermely a. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):903-913. doi: 10.1016/S2468-1253(21)00308-3. Epub 2021 Sep 21. Lancet Gastroenterol Hepatol. 2021. PMID: 34555346

4

Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis.

Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, Tilg H, Byrne CD, Targher G. Mantovani A, et al. Among authors: csermely a. Gut. 2022 Jan;71(1):156-162. doi: 10.1136/gutjnl-2020-323082. Epub 2020 Dec 10. Gut. 2022. PMID: 33303564

5

Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals.

Mantovani A, Csermely A, Tilg H, Byrne CD, Targher G. Mantovani A, et al. Among authors: csermely a. Gut. 2023 Jul;72(7):1433-1436. doi: 10.1136/gutjnl-2022-328224. Epub 2022 Aug 24. Gut. 2023. PMID: 36002249 No abstract available.

6

Crosstalk between genetic variability of adiponectin and leptin, glucose-insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14.

Zusi C, Csermely A, Rinaldi E, Bertoldo K, Bonetti S, Boselli ML, Travia D, Bonora E, Bonadonna RC, Trombetta M. Zusi C, et al. Among authors: csermely a. Diabetes Obes Metab. 2023 Sep;25(9):2650-2658. doi: 10.1111/dom.15152. Epub 2023 Jun 19. Diabetes Obes Metab. 2023. PMID: 37334519

7

Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study.

Mantovani A, Csermely A, Castagna A, Antinori E, Danese E, Zusi C, Sani E, Ravaioli F, Colecchia A, Maffeis C, Valenti L, Girelli D, Targher G. Mantovani A, et al. Among authors: csermely a. Liver Int. 2023 Nov;43(11):2434-2444. doi: 10.1111/liv.15649. Epub 2023 Jun 14. Liver Int. 2023. PMID: 37312616

8

Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.

Csermely A, Mantovani A, Morieri ML, Palmisano L, Masulli M, Cossu E, Baroni MG, Bonomo K, Cimini FA, Cavallo G, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Pollis RM, Aldigeri R, Cas AD, de Kreutzenberg SV, Targher G. Csermely A, et al. Diabetes Metab. 2023 Nov;49(6):101477. doi: 10.1016/j.diabet.2023.101477. Epub 2023 Sep 12. Diabetes Metab. 2023. PMID: 37708990

9

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.

Mantovani A, Petracca G, Csermely A, Beatrice G, Targher G. Mantovani A, et al. Among authors: csermely a. Metabolites. 2020 Dec 30;11(1):22. doi: 10.3390/metabo11010022. Metabolites. 2020. PMID: 33396949 Free PMC article. Review.

10

Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project.

Pasquini S, Rinaldi E, Da Prato G, Csermely A, Indelicato L, Zaffani S, Santi L, Sabbion A, Maffeis C, Bonora E, Trombetta M. Pasquini S, et al. Among authors: csermely a. Diabet Med. 2022 Apr;39(4):e14719. doi: 10.1111/dme.14719. Epub 2021 Oct 23. Diabet Med. 2022. PMID: 34657317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year